Skip to main content

BCRX

BIOCRYST PHARMACEUTICALS INC
Last price
$9.06
As of

Active signals for BCRX

No recent signals on BCRX in the last 180 days.

Top institutional holders of BCRX (13F)

FundMarket value% portfolioQoQ
TWO SIGMA INVESTMENTS, LP$60.9M0.05%+41.6%
TWO SIGMA INVESTMENTS, LP$35.2M0.05%+2.2%
TWO SIGMA INVESTMENTS, LP$33.5M0.05%,
RENAISSANCE TECHNOLOGIES LLC$16.6M0.03%-0.5%
RENAISSANCE TECHNOLOGIES LLC$16.2M0.02%,
D. E. Shaw & Co., Inc.$9.7M0.01%+72.0%
Point72 Asset Management, L.P.$9.5M0.01%+409.5%
RENAISSANCE TECHNOLOGIES LLC$7.4M0.01%-63.5%
Bridgewater Associates, LP$6.1M0.03%+170.9%
D. E. Shaw & Co., Inc.$5.5M0.00%,
Bridgewater Associates, LP$3.1M0.01%,
D. E. Shaw & Co., Inc.$2.9M0.00%-75.8%
Bridgewater Associates, LP$1.8M0.01%-42.8%
Point72 Asset Management, L.P.$1.8M0.00%,
CITADEL ADVISORS LLC$1M0.00%+13.8%
CITADEL ADVISORS LLC$878K0.00%,

Sourced from quarterly 13F filings with the U.S. Securities and Exchange Commission.

Recent SEC filings, BCRX

See more BCRX signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Sign in to track BCRX in your watchlist and get notified the moment a new signal fires.

Track BCRX on Kresmion →